Stock AnalizCIMPRESS plc CMPR
Publishing · IPO 2005 · data as of November 13, 2026
CIMPRESS plc (CMPR) is a consumer discretionary company listed in the US with a market value of about $1.4B. In the twelve months to September 30, 2026 it had revenue of $3.8B and net income of $86M, a net margin of 2.2%.
Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is value (4/5); the weakest is track record (0/5).
Key numbers: a P/E of 17.0, a price to free cash flow of 7.4, 5-year revenue growth of 8% a year, a 5-year average ROIC of 11%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 45% above the current price.
Score: 2.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year free cash flow growth above 10% a year
- Positive free cash flow
- Interest covered more than 5 times
- Share count down over 3 years (buybacks)
Checks not passed
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8B | $3.7B | $3.4B | $3.3B | $3.1B | $2.9B | $2.6B | $2.5B | $2.8B | $2.6B | $2.1B |
| Net income | $86M | $96M | $15M | $174M | -$186M | -$54M | -$85M | $83M | $95M | $44M | -$72M |
| Free cash flow | $191M | $183M | $209M | $296M | $77M | $165M | $227M | $288M | $261M | $131M | $83M |
| EPS (diluted) | $3.37 | $3.79 | $0.58 | $6.43 | $-7.08 | $-2.08 | $-3.28 | $3.00 | $3.00 | $1.36 | $-2.29 |
| Net margin | 2.2% | 2.6% | 0.4% | 5.3% | -6.0% | -1.9% | -3.3% | 3.4% | 3.5% | 1.7% | -3.4% |
| ROIC | — | 12.8% | 16.4% | 17.2% | 4.1% | 2.9% | 7.0% | 3.7% | 11.3% | 12.1% | -4.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $96.00, 68% above the current price; targets range from $90.00 to $102.00; the consensus rating is “Strong buy”; expected EPS is $3.90 for the fiscal year ending June 30, 2027.
Frequently asked questions
What is CIMPRESS’s P/E ratio?
About 17.0, based on the last twelve months of diluted earnings per share (forward P/E about 9.7).
Is CIMPRESS stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 45% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does CIMPRESS pay a dividend?
Not currently.
Is CIMPRESS a good stock to buy?
We do not give buy or sell advice. CIMPRESS scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.